The Cyprus Institute of Neurology and Genetics (CING) plays a central role in the research, treatment and prevention of thalassaemia, according to the Molecular Genetics Thalassaemia Department, which states that around 1,700 samples of thalassaemia patients and about 110 of the types of hemoglobinopathies are examined annually.